334 related articles for article (PubMed ID: 28289769)
1. Gene Therapy.
Thorne B; Takeya R; Vitelli F; Swanson X
Adv Biochem Eng Biotechnol; 2018; 165():351-399. PubMed ID: 28289769
[TBL] [Abstract][Full Text] [Related]
2. scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution.
Öztürk BE; Johnson ME; Kleyman M; Turunç S; He J; Jabalameli S; Xi Z; Visel M; Dufour VL; Iwabe S; Pompeo Marinho LFL; Aguirre GD; Sahel JA; Schaffer DV; Pfenning AR; Flannery JG; Beltran WA; Stauffer WR; Byrne LC
Elife; 2021 Oct; 10():. PubMed ID: 34664552
[TBL] [Abstract][Full Text] [Related]
3. Manufacturing Challenges and Rational Formulation Development for AAV Viral Vectors.
Srivastava A; Mallela KMG; Deorkar N; Brophy G
J Pharm Sci; 2021 Jul; 110(7):2609-2624. PubMed ID: 33812887
[TBL] [Abstract][Full Text] [Related]
4. Treatment to cure: Advancing AAV gene therapy manufacture.
Young P
Drug Discov Today; 2023 Jul; 28(7):103610. PubMed ID: 37169134
[TBL] [Abstract][Full Text] [Related]
5. Moving from the bench towards a large scale, industrial platform process for adeno-associated viral vector purification.
Adams B; Bak H; Tustian AD
Biotechnol Bioeng; 2020 Oct; 117(10):3199-3211. PubMed ID: 32573761
[TBL] [Abstract][Full Text] [Related]
6. Production, Processing, and Characterization of Synthetic AAV Gene Therapy Vectors.
El Andari J; Grimm D
Biotechnol J; 2021 Jan; 16(1):e2000025. PubMed ID: 32975881
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
Ulrich-Vinther M
Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
[TBL] [Abstract][Full Text] [Related]
8. Non-viral gene therapy: Gains and challenges of non-invasive administration methods.
Foldvari M; Chen DW; Nafissi N; Calderon D; Narsineni L; Rafiee A
J Control Release; 2016 Oct; 240():165-190. PubMed ID: 26686079
[TBL] [Abstract][Full Text] [Related]
9. Lentiviral Vector Bioprocessing.
Perry C; Rayat ACME
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572347
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective.
Jt S; M H; Wam B; Ac B; Sa N
J Mol Med (Berl); 2022 Jun; 100(6):875-901. PubMed ID: 35606652
[TBL] [Abstract][Full Text] [Related]
11. Adeno-associated virus vector as a platform for gene therapy delivery.
Wang D; Tai PWL; Gao G
Nat Rev Drug Discov; 2019 May; 18(5):358-378. PubMed ID: 30710128
[TBL] [Abstract][Full Text] [Related]
12. Biosafety of recombinant adeno-associated virus vectors.
Dismuke DJ; Tenenbaum L; Samulski RJ
Curr Gene Ther; 2013 Dec; 13(6):434-52. PubMed ID: 24195602
[TBL] [Abstract][Full Text] [Related]
13. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
14. Progress and challenges in viral vector manufacturing.
van der Loo JC; Wright JF
Hum Mol Genet; 2016 Apr; 25(R1):R42-52. PubMed ID: 26519140
[TBL] [Abstract][Full Text] [Related]
15. Development and Delivery of a Hands-On Short Course in Adeno-Associated Virus Manufacturing to Support Growing Workforce Needs in Gene Therapy.
Overton L; Boi C; Shastry S; Smith-Moore C; Balchunas J; Sambandan D; Gilleskie G
Hum Gene Ther; 2023 Apr; 34(7-8):259-272. PubMed ID: 36860188
[TBL] [Abstract][Full Text] [Related]
16. Clinical grade lentiviral vector purification and quality control requirements.
Shi R; Jia S; Liu H; Nie H
J Sep Sci; 2022 Jun; 45(12):2093-2101. PubMed ID: 35247228
[TBL] [Abstract][Full Text] [Related]
17. Commercial Scale Manufacturing of Allogeneic Cell Therapy.
Pigeau GM; Csaszar E; Dulgar-Tulloch A
Front Med (Lausanne); 2018; 5():233. PubMed ID: 30186836
[TBL] [Abstract][Full Text] [Related]
18. Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a "modified" step-filtration process for clearance of packaging cells.
Feldman SA; Goff SL; Xu H; Black MA; Kochenderfer JN; Johnson LA; Yang JC; Wang Q; Parkhurst MR; Cross S; Morgan RA; Cornetta K; Rosenberg SA
Hum Gene Ther; 2011 Jan; 22(1):107-15. PubMed ID: 20662590
[TBL] [Abstract][Full Text] [Related]
19. Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale.
Lock M; Alvira M; Vandenberghe LH; Samanta A; Toelen J; Debyser Z; Wilson JM
Hum Gene Ther; 2010 Oct; 21(10):1259-71. PubMed ID: 20497038
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy in cystic fibrosis.
Flotte TR; Laube BL
Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
